The Drug and Alcohol Clinical Advisory Service: A model of telephone-delivered addiction specialist support
The Drug and Alcohol Clinical Advisory Service: A model of telephone-delivered addiction specialist support
复制标题
DOI：
10.1111/dar.13035
复制
发表时间：
2020-01-23
影响因子：
3.8
通讯作者：
Lubman, Dan I.
中科院分区：
文献类型：
--
作者：
Grigg, Jasmin;Arunogiri, Shalini;Lubman, Dan I.
引言和目标是有药物使用问题的人经常向主流卫生服务机构提出各种健康问题。然而，许多医疗和盟军医疗保健提供者觉得没有足够的装备来应对这一群体。我们描述了药物和酒精临床咨询服务(DACAS)，这是一种建立的24/7全天候电话传输的成瘾专家咨询模式，并检查最近的呼叫数据，以确定卫生工作者寻求支持的药物使用问题。给出了DACAS业务提供和呼叫数据采集的设计和方法方法。对2013年7月至2018年6月期间定期收集的呼叫数据进行了回顾，提取了有关呼叫和呼叫者特征以及咨询详细信息的信息。结果在2013-2018年间，DACAS响应了6565个电话，每年为维多利亚、塔斯马尼亚和北领地的1200多名从业者提供专业酒精和其他药物支持。与大都市地区的从业者相比，地区性和边远地区从业者的服务使用率更高。阿片激动剂治疗是医生寻求咨询的最常见的药物类别(39.5%)，其次是其他阿片类药物(19.4%)。咨询模式因呼叫者的职业、服务环境和地点而异。讨论和结论DACAS正在为获得专科成瘾治疗的挑战提供多州一级的应对措施，特别是阿片激动剂治疗和其他阿片类药物问题，并在区域和偏远地区表现出吸收。这种电话提供的服务提供了一个机会，扩大阿片类药物使用障碍和其他药物使用问题的治疗机会，特别是在获得专家成瘾护理的机会较少的地区。
Introduction and Aims People with substance use problems frequently present to mainstream health services with a variety of health issues. However, many medical and allied health-care providers feel under-equipped to respond to this population. We describe the Drug and Alcohol Clinical Advisory Service (DACAS), an established 24/7 telephone-delivered model of addiction specialist consultation, and examine recent call data to identify drug use issues for which health practitioners seek support. Design and Methods Methods of DACAS service provision and call data collection are provided. A retrospective review of routinely collected call data between July 2013 and June 2018 was performed, extracting information on call and caller characteristics, and consultation details. Results During 2013-2018, DACAS responded to 6565 calls, providing access to specialist alcohol and other drug support for more than 1200 practitioners across Victoria, Tasmania and the Northern Territory annually. Higher rates of service use were found among practitioners located in regional and remote areas, relative to those in metropolitan areas. Opioid agonist treatment was the most common drug class for which practitioners sought consultation (39.5%), followed by other opioids (19.4%). Advice-seeking patterns differed according to caller profession, service setting and location. Discussion and Conclusions DACAS is providing a multistate-level response to the challenges of accessing specialist addiction treatment, particularly for opioid agonist treatment and other opioid issues, with demonstrated uptake in regional and remote areas. This telephone-delivered service provides an opportunity to expand access to treatment for opioid use disorder and other substance use problems, particularly in areas with less equitable access to specialist addiction care.